On August 12, 2024, Safety Shot, Inc., a wellness and dietary supplement company, announced the results of a clinical trial that demonstrated its product's ability to significantly reduce Blood Alcohol Content (BAC) in consumers. The trial, conducted by The Center for Applied Health Sciences (CAHS), was a double-blind, randomized, placebo-controlled study that showed a 30%-50% faster reduction in BAC when participants consumed Safety Shot compared to a placebo. The participants, aged 24 to 46, experienced not only a rapid decrease in BAC but also reported less head discomfort, reduced fatigue, and improved concentration. The company's COO, David Sandler, highlighted the decade of research and development behind the product, which is now clinically proven to aid in the rapid reduction of alcohol...Show More

On August 12, 2024, Safety Shot, Inc., a wellness and dietary supplement company, announced the results of a clinical trial that demonstrated its product's ability to significantly reduce Blood Alcohol Content (BAC) in consumers. The trial, conducted by The Center for Applied Health Sciences (CAHS), was a double-blind, randomized, placebo-controlled study that showed a 30%-50% faster reduction in BAC when participants consumed Safety Shot compared to a placebo. The participants, aged 24 to 46, experienced not only a rapid decrease in BAC but also reported less head discomfort, reduced fatigue, and improved concentration. The company's COO, David Sandler, highlighted the decade of research and development behind the product, which is now clinically proven to aid in the rapid reduction of alcohol in the body. The study's findings are being prepared for submission to a biomedical journal for peer review. Safety Shot is available for purchase online and is expanding its business-to-business sales throughout 2024. The press release also contained forward-looking statements regarding the product's development and commercialization, as well as the company's compliance with laws and potential risks.